Results 61 to 70 of about 7,846,955 (114)
Ocular Graft versus Host Disease
Allogeneic hematopoietic stem cell transplantation is considered the standard of care for hematological and lymphoid malignancies. One of the complications associated to this therapy is an immune-mediated reaction known as graft versus host disease with ...
Paulo E.C. Dantas
core +1 more source
Management of Ocular Graft-Versus-Host Disease: A Brief Review [PDF]
Graft-versus-host disease (GVHD) remains a major complication following hematopoietic stem cell transplantation (HSCT). Ocular GVHD develops in a substantial number of patients following HSCT and 60 % to 90 % of patients with systemic GVHD experience the
Soleimani, Mohammad, Samadi , Melika
core +1 more source
Suicide gene therapy for graft-versus-host disease
In allogeneic hematopoietic stem cell transplantation, donor-derived T cells are key players for early immune reconstitution and efficient engraftment, as well as the graft-versus-leukemia and graft-versus-infection effects.
Evren Alici +5 more
core +1 more source
Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease
Acute graft-vs.-host disease (aGVHD) is a frequent complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), accounting for substantial morbidity and mortality associated with this treatment modality.
Nina C. Zitzer +3 more
doaj +1 more source
Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells
Graft versus host disease, an alloimmune attack on host tissues mounted by donor T cells, is the most important toxicity of allogeneic bone marrow transplantation. The mechanism by which allogeneic T cells are initially stimulated is unknown. In a murine
Matthew S. Couzens +7 more
core +1 more source
The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
Allogeneic hematopoietic cell transplantation (allo-HCT) is performed with curative intent for high- risk blood cancers and bone marrow failure syndromes; yet the development of acute and chronic graft-vs.-host disease (GVHD) remain preeminent causes of ...
David Bastian +4 more
doaj +1 more source
Impact of cytokine gene polymorphisms on graft-vs-host disease
Allogeneic hematopoietic stem cell transplantation (SCT) remains the only available curative therapy for hematological malignancy. It does, however, result in significant morbidity and mortality, predominantly as a consequence of infections, leukemic ...
Markey, K. A. +2 more
core +1 more source
Combination of pleuroparenchymal fibroelastosis with non-specific interstitial pneumonia and bronchiolitis obliterans as a complication of hematopoietic stem cell transplantation — Clues to a potential mechanism [PDF]
Pleuroparenchymal fibroelastosis (PPFE) is a newly described entity of interstitial lung disease,which has been recently recognized as a rare complication of bone marrow transplantation.
Bychkov, Andrey +11 more
core +1 more source
Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice
A murine model for acute lethal graft vs. host disease (GVHD) was used to study the role that a number of cytokines play in the development of lethal GVHD. In this study we focused on the role of IL-1, IL-2, IL-4, IL-6, IFN-γ and TNF-α.
A. C. Knulst +6 more
doaj +1 more source
Pulmonary graft vs. host disease is a diverse and underestimated complication following allogenic hematopoietic stem cell transplantation. We aimed to compare the airway architecture with chronic lung allograft dysfunction post lung transplantation ...
Dubbeldam, Adriana +23 more
core +1 more source

